Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)

C. C. Liao; P. L. Chou; C. W. Cheng; Y. S. Chang; W. M. Chi; K. L. Tsai; W. J. Chen; T. S. Kung; C. C. Tai; K. W. Lee; Y. C. Chen; C. Y. Lin

doi:10.1016/j.jprot.2018.11.016

Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)

C. C. Liao, P. L. Chou, C. W. Cheng, Y. S. Chang, W. M. Chi, K. L. Tsai, W. J. Chen, T. S. Kung, C. C. Tai, K. W. Lee, Y. C. Chen, C. Y. Lin

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

The authors would like to apologize for any inconvenience caused. The affiliation of the author YS Chang should correct to “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.” instead of “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.” I apologize for the inconvenience.

原文	英語
頁（從 - 到）	227
頁數	1
期刊	Journal of Proteomics
卷	194
DOIs	https://doi.org/10.1016/j.jprot.2018.11.016
出版狀態	已發佈 - 3月 1 2019

ASJC Scopus subject areas

生物物理學
生物化學

存取文件

10.1016/j.jprot.2018.11.016

其它文件與鏈接

指紋

深入研究「Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)」主題。共同形成了獨特的指紋。

引用此

Liao, C. C., Chou, P. L., Cheng, C. W., Chang, Y. S., Chi, W. M., Tsai, K. L., Chen, W. J., Kung, T. S., Tai, C. C., Lee, K. W., Chen, Y. C., & Lin, C. Y. (2019). Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031). Journal of Proteomics, 194, 227. https://doi.org/10.1016/j.jprot.2018.11.016

Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031). / Liao, C. C.; Chou, P. L.; Cheng, C. W. 等.
於: Journal of Proteomics, 卷 194, 01.03.2019, p. 227.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Liao, CC, Chou, PL, Cheng, CW , Chang, YS, Chi, WM, Tsai, KL, Chen, WJ, Kung, TS, Tai, CC, Lee, KW, Chen, YC & Lin, CY 2019, 'Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)', Journal of Proteomics, 卷 194, 頁 227. https://doi.org/10.1016/j.jprot.2018.11.016

Liao CC, Chou PL, Cheng CW , Chang YS, Chi WM, Tsai KL 等. Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031). Journal of Proteomics. 2019 3月 1;194:227. doi: 10.1016/j.jprot.2018.11.016

Liao, C. C. ; Chou, P. L. ; Cheng, C. W. 等. / Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141 : (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031). 於: Journal of Proteomics. 2019 ; 卷 194. 頁 227.

@article{1cd5023308434265b66103aee1538e13,

title = "Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sj{\"o}gren's syndrome and secondary Sj{\"o}gren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)",

abstract = "The authors would like to apologize for any inconvenience caused. The affiliation of the author YS Chang should correct to “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.” instead of “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.” I apologize for the inconvenience.",

author = "Liao, {C. C.} and Chou, {P. L.} and Cheng, {C. W.} and Chang, {Y. S.} and Chi, {W. M.} and Tsai, {K. L.} and Chen, {W. J.} and Kung, {T. S.} and Tai, {C. C.} and Lee, {K. W.} and Chen, {Y. C.} and Lin, {C. Y.}",

note = "Publisher Copyright: {\textcopyright} 2018",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/j.jprot.2018.11.016",

language = "English",

volume = "194",

pages = "227",

journal = "Journal of Proteomics",

issn = "1874-3919",

publisher = "Elsevier",

}

TY - JOUR

T1 - Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141

T2 - (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)

AU - Liao, C. C.

AU - Chou, P. L.

AU - Cheng, C. W.

AU - Chang, Y. S.

AU - Chi, W. M.

AU - Tsai, K. L.

AU - Chen, W. J.

AU - Kung, T. S.

AU - Tai, C. C.

AU - Lee, K. W.

AU - Chen, Y. C.

AU - Lin, C. Y.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - The authors would like to apologize for any inconvenience caused. The affiliation of the author YS Chang should correct to “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.” instead of “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.” I apologize for the inconvenience.

AB - The authors would like to apologize for any inconvenience caused. The affiliation of the author YS Chang should correct to “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.” instead of “4 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.” I apologize for the inconvenience.

UR - http://www.scopus.com/inward/record.url?scp=85058163175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058163175&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2018.11.016

DO - 10.1016/j.jprot.2018.11.016

M3 - Comment/debate

C2 - 30553786

AN - SCOPUS:85058163175

SN - 1874-3919

VL - 194

SP - 227

JO - Journal of Proteomics

JF - Journal of Proteomics

ER -